Literature DB >> 8519519

Reactive thrombocytosis after coronary bypass surgery. An important risk factor.

M Schmuziger1, J T Christenson, J Maurice, F Simonet, V Velebit.   

Abstract

Reactive thrombocytosis (RT) has earlier been reported to occur as a response to various situations and conditions, such as post-splenectomy, hematopoietic disorders, major trauma and operations, neoplasms and inflammations. In cardiac surgery the main interest has focused on thrombocytopenia that occurs after cardiopulmonary bypass (CPB) and the risk of postoperative bleeding, rather than the possibility of a late occurrence of RT as a risk factor for thrombotic complications after coronary artery bypass grafting (CABG). Between 1989 and 1992, on routine blood examinations we noticed a group of CABG patients (n = 297, Group II, 19.5%) that, 1 week after operation, showed thrombocytosis with significantly increased platelet count (521 +/- 96 x 10(3)/mm3) compared to patients with normal platelet counts (Group I, n = 1521, 185 +/- 125 x 10(3)/mm3); P < 0.001. Patient characteristics, coronary angiography findings, operative data and perioperative complications were analyzed for the two groups. There were significantly more patients with hyperlipidemia, smoking and previous myocardial infarction in Group II than in Group I; P < 0.05. Age, sex, clinical characteristics, angiography findings and operative data did not differ between the groups. There were no differences in postoperative bleeding or the need of transfusion between the groups. However, Group II (RT) patients had significantly more postoperative myocardial infarctions, 4.4% compared to 0.7% Group I; P < 0.001. Early symptomatic vein graft occlusion (0-7 days postoperatively) was not different between the groups, while there were significantly move late symptomatic vein graft occlusions (7-60 days postoperatively) in Group II (RT) 4.4% than in Group I 1.1%; P < 0.001.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 8519519     DOI: 10.1016/s1010-7940(05)80172-1

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

1.  Etiology and clinical relevance of elevated platelet count in ICU patients : A retrospective analysis.

Authors:  M Banach; C Lautenschläger; P Kellner; J Soukup
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-03-31       Impact factor: 0.840

Review 2.  [Iron deficiency, thrombocytosis and thromboembolism].

Authors:  Rayko Evstatiev
Journal:  Wien Med Wochenschr       Date:  2016-09-28

3.  Reactive thrombocytosis in H1N1 infection.

Authors:  T Samra; M Pawar
Journal:  J Lab Physicians       Date:  2011-07

4.  Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.

Authors:  Jonathan S Bleeker; William J Hogan
Journal:  Thrombosis       Date:  2011-06-08

5.  Bilateral visual loss and cerebral infarction after spleen embolization in a trauma patient with idiopathic thrombocytopenic purpura: A case report.

Authors:  Wei-Ting Wang; Yu-Yu Li; Wan-Ching Lin; Jen-Yin Chen; Kuo-Mao Lan; Cheuk-Kwan Sun; Kuo-Chuan Hung
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

6.  Low-level light therapy reduces platelet destruction during extracorporeal circulation.

Authors:  Anna Drohomirecka; Alicja Iwaszko; Tomasz Walski; Aleksandra Pliszczak-Król; Grzegorz Wąż; Stanisław Graczyk; Katarzyna Gałecka; Albert Czerski; Jolanta Bujok; Małgorzata Komorowska
Journal:  Sci Rep       Date:  2018-11-16       Impact factor: 4.379

7.  Increased blood product use among coronary artery bypass patients prescribed preoperative aspirin and clopidogrel.

Authors:  Joel G Ray; Stacy Deniz; Anthony Olivieri; Erika Pollex; Marian J Vermeulen; Kurian S Alexander; David J Cain; Irene Cybulsky; Cindy M Hamielec
Journal:  BMC Cardiovasc Disord       Date:  2003-05-22       Impact factor: 2.298

8.  Predictable Risk Factors of Upper-Extremity Deep Venous Thrombosis in a Level I Trauma Center.

Authors:  Scarlett Tohme; Aparna Vancheswaran; Kyle Mobbs; Jessica Kydd; Nisha Lakhi
Journal:  Int J Gen Med       Date:  2021-06-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.